288 The COX-2 pathway as a mediator of resistance to anti-PD-1 therapy
Shuming Chen,
Tracee McMiller,
Suzanne Topalian,
Preethi Sankaran,
Kyle Kampta
Affiliations
Shuming Chen
Aff230 grid.21107.350000000121719311Department of Surgery, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg-Kimmel Institute for Cancer Immunotherapy Baltimore MD USA
Tracee McMiller
Aff230 grid.21107.350000000121719311Department of Surgery, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg-Kimmel Institute for Cancer Immunotherapy Baltimore MD USA
Suzanne Topalian
Aff230 grid.21107.350000000121719311Department of Surgery, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg-Kimmel Institute for Cancer Immunotherapy Baltimore MD USA
Preethi Sankaran
Teneobio, Inc, Newark, California, USA
Kyle Kampta
Johns Hopkins University School of Medicine, Baltimore, MD, USA
